Abstract
Background
Preoperative HbA1c has been associated with an increased incidence of postoperative morbidity and mortality after abdominal and cardiovascular surgery. The literature on bariatric surgery is inconclusive and guidelines recommend postponement of surgery when HbA1c is above an arbitrary threshold (≥ 8.5%). In this study, we sought to understand the impact of preoperative HbA1c on early and late postoperative complications.
Methods
We performed a retrospective analysis of prospectively collected data on obese patients with diabetes who underwent laparoscopic bariatric surgery. Patients were categorized into three groups according to their preoperative HbA1c level: < 6.5% (group 1), 6.5–8.4% (group 2) and ≥ 8.5% (group 3). Primary outcomes were early and late postoperative complications (< and > 30 days, respectively) that were differentiated based on severity (major/minor). Secondary outcomes were length of stay (LOS), duration of surgery, and rate of readmission.
Results
In total, 6798 patients underwent laparoscopic bariatric surgery from 2006 to 2016, of which 1021 (15%) patients had Type 2 Diabetes (T2D). Complete data with a median follow-up of 45 months (3–120) were available for 914 patients with HbA1c < 6.5% (n = 227, 24.9%), 6.5–8.4% (n = 532, 58.5%) and ≥ 8.5% (n = 152, 16.6%). Early major surgical complication rate was similar across the groups ranging from 2.6 to 3.3%. No associations between high preoperative HbA1c and late complications—medical as well as surgical—was observed. Groups 2 and 3 had statistically significant more pronounced inflammatory status. LOS (1.8–1.9 days), readmission rates (1.7–2.0%) and surgical time was similar across the three groups.
Conclusion
Elevated HbA1c is not associated with more early or late postoperative complications, longer LOS, longer surgical time or higher rates of readmission.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.
References
Bock M, Johansson T, Fritsch G, Flamm M, Hansbauer B, Mann E, Sönnichsen A (2015) The impact of preoperative testing for blood glucose concentration and haemoglobin A1c on mortality, changes in management and complications in noncardiac elective surgery: a systematic review. Eur J Anaesthesiol. https://doi.org/10.1097/EJA.0000000000000117
Levy N, Dhatariya K (2019) Pre-operative optimisation of the surgical patient with diagnosed and undiagnosed diabetes: a practical review. Anaesthesia. https://doi.org/10.1111/anae.14510
Gustafsson UO, Thorell A, Soop M, Ljungqvist O, Nygren J (2009) Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg. https://doi.org/10.1002/bjs.6724
Goh SN, Yeoh E, Tan KY (2017) Impact of perioperative hypoglycaemia in subjects with diabetes undergoing colorectal surgery. Int J Colorectal Dis. https://doi.org/10.1007/s00384-016-2680-9
Feringa HH, Vidakovic R, Karagiannis SE, Dunkelgrun M, Elhendy A, Boersma E, van Sambeek MR, Noordzij PG, Bax JJ, Poldermans D (2008) Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med. https://doi.org/10.1111/j.1464-5491.2007.02352.x
Jämsen E, Nevalainen P, Kalliovalkama J, Moilanen T (2010) Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. https://doi.org/10.1016/j.ejim.2010.02.006
Goodenough CJ, Liang MK, Nguyen MT, Nguyen DH, Holihan JL, Alawadi ZM, Roth JS, Wray CJ, Ko TC, Kao LS (2015) Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg. https://doi.org/10.1016/j.jamcollsurg.2015.07.013
Dhatariya K, Flanagan D, Hilton L, Kilvert A, Levy N, Rayman G, Watson B (2011) Management of adults with diabetes undergoing surgery and elective procedures: improving standards. Available at http://www.diabetologists-abcd.org.uk/jbds/JBDS_IP_Surgery_Adults_Full.pdf; Accessed Jan 2020
Dhatariya K, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, Hilton L, Jairam C, Leyden K, Lipp A, Lobo D, Sinclair-Hammersley M, Rayman G, Joint British Diabetes Societies (2012) NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. https://doi.org/10.1111/j.1464-5491.2012.03582.x
Membership of the Working Party, Barker P, Creasey PE, Dhatariya K, Levy N, Lipp A, Nathanson MH, Penfold N, Watson B, Woodcock T (2015) Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. https://doi.org/10.1111/anae.13233.2015
Joshi GP, Chung F, Vann MA, Ahmad S, Gan TJ, Goulson DT, Merrill DG, Twersky R (2010) Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg. https://doi.org/10.1213/ANE.0b013e3181f9c288
Stenberg E, Cao Y, Szabo E, Näslund E, Näslund I, Ottosson J (2018) Risk prediction model for severe postoperative complication in bariatric surgery. Obes Surg. https://doi.org/10.1007/s11695-017-3099-2
Chuah LL, Miras AD, Papamargaritis D, Jackson SN, Olbers T, le Roux CW (2015) Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery. Surg Obes Relat Dis. https://doi.org/10.1016/j.soard.2014.11.004
Perna M, Romagnuolo J, Morgan K, Byrne TK, Baker M (2012) Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity. Surg Obes Relat Dis. https://doi.org/10.1016/j.soard.2011.08.002
Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Effect of elevated hemoglobin A1c in diabetic patients on complication rates after Roux-en-Y gastric bypass. Surg Obes Relat Dis. https://doi.org/10.1016/j.soard.2012.06.011
Zaman JA, Shah N, Leverson GE, Greenberg JA, Funk LM (2017) The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery. Surg Endosc. https://doi.org/10.1007/s00464-016-5129-x
Yan G, Wang J, Zhang J, Gao K, Zhao Q, Xu X (2019) Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis. PLoS One. https://doi.org/10.1371/journal.pone.0224828
Jacobsen HJ, Bergland A, Raeder J, Gislason HG (2012) High-volume bariatric surgery in a single center: safety, quality, cost-efficacy and teaching aspects in 2000 consecutive cases. Obes Surg. https://doi.org/10.1007/s11695-011-0557-0
Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, Ballem N, Kligman M, Kothari S, ASMBS Clinical Issues Committee (2015) Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. https://doi.org/10.1016/j.soard.2015.02.003
Wysocki M, Walędziak M, Hady HR, Czerniawski M, Proczko-Stepaniak M, Szymański M, Dowgiałło-Wnukiewicz N, Kozera P, Szeliga J, Orłowski M, Pędziwiatr M, Szopa M, Budzyński A, Major P (2019) Type 2 diabetes mellitus and preoperative hba1c level have no consequence on outcomes after laparoscopic sleeve gastrectomy-a cohort study. Obes Surg. https://doi.org/10.1007/s11695-019-03936-y
Ortega CB, Lee HJ, Portenier D, Guerron AD, Tong J (2018) Preoperative hemoglobin A1c predicts postoperative weight loss following bariatric surgery in patients with diabetes. Diabetes. https://doi.org/10.2337/db18-2045-P
Basishvili G, Yang J, Nie L, Docimo S Jr, Pryor AD, Spaniolas K (2021) HbA1C is not directly associated with complications of bariatric surgery. Surg Obes Relat Dis. https://doi.org/10.1016/j.soard.2020.10.009
Nwokedi U, Zia M, Xu J, Sadhu AR, Baio FE, Kash BS, Sherman V, Tariq N (2022) Elevated hemoglobin A1c level and bariatric surgery complications. Surg Endosc. https://doi.org/10.1007/s00464-022-09030-2
Pina L, Dove J, Wood GC, Parker DM, Still C, Petrick A, Daouadi M (2022) Stratified preoperative A1c is not significantly associated with Clavien-Dindo major complications following bariatric surgery in the MBSAQIP database. Am Surg. https://doi.org/10.1177/000313482211215512022
Samuel N, Mustafa A, Hawkins H, Wei N, Boyle M, De Alwis N, Small P, Mahawar K, Carr W (2022) Influence of pre-operative HbA1c on bariatric surgery outcomes-the Sunderland (UK) experience. Obes Surg. https://doi.org/10.1007/s11695-021-05741-y
Aminian A, Kashyap SR, Burguera B, Punchai S, Sharma G, Froylich D, Brethauer SA, Schauer PR (2016) Incidence and clinical features of diabetic ketoacidosis after bariatric and metabolic surgery. Diabetes Care. https://doi.org/10.2337/dc15-2647
Kirwan JP, Aminian A, Kashyap SR, Burguera B, Brethauer SA, Schauer PR (2016) Bariatric surgery in obese patients with type 1 diabetes. Diabetes Care. https://doi.org/10.2337/dc15-2732
Jadoon KA, Van der Wijngaart HA, Olczak SA (2018) Bariatric surgery does not cure all type 2 diabetes. BMJ Case Rep. https://doi.org/10.1136/bcr.08.2008.0755
Rizo IM, Apovian CM (2015) Diabetic ketoacidosis post bariatric surgery. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2018.00812
Mulla CM, Baloch HM, Hafida S (2019) Management of diabetes in patients undergoing bariatric surgery. Curr Diab Rep. https://doi.org/10.1007/s11892-019-1242-2
Calle MC, Fernandez ML (2012) Inflammation and type 2 diabetes. Diabetes Metab. https://doi.org/10.1016/j.diabet.2011.11.006
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. https://pubmed.ncbi.nlm.nih.gov/16613757/. Accessed 1 Dec 2021
Rao SR (2012) Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res. https://doi.org/10.1007/s00011-012-0473-3
Miller GD, Nicklas BJ, Fernandez A (2011) Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. https://doi.org/10.1016/j.soard.2011.03.006
Jones CE, Graham LA, Morris MS, Richman JS, Hollis RH, Wahl TS, Copeland LA, Burns EA, Itani KMF, Hawn MT (2017) Association between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and readmissions following gastrointestinal surgery. JAMA Surg. https://doi.org/10.1001/jamasurg.2017.2350
Funding
The authors received no specific funding for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors (Kamran Shah, Ismail Gögenur and Hjörtur Gislason) have no commercial or financial associations that might be of conflict of interest in relation to this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shah, K., Gögenur, I. & Gislason, H. High preoperative HbA1c does not affect early or late complication rates after bariatric surgery. Surg Endosc 37, 5313–5319 (2023). https://doi.org/10.1007/s00464-023-10009-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-023-10009-w